MarketsBeta

Platform in test version·information shown is for guidance only and does not constitute investment advice.

UMED

UNIMED

Continuous
8.710TND
-0.46%(-0.040)
Sector
Health Care
Market Cap
278.72M TND
ISIN
TN0007720014
Today's Session
Prev Close
8.750
Open
8.740
High
8.750
Low
8.710
Thresholds
8.230 - 9.270
Volume
124.8K
14,274 shares
Performance
YTD Change
-7.83%
20D Volatility
28.50%
Annualized
52W High
11.000
52W Low
7.900

About UNIMED

View all

UNIMED is a Tunisian pharmaceutical manufacturer specializing in sterile products: injectables, eye drops, ophthalmic solutions, and infusion fluids. Founded in 1989 in Sousse and listed since 2016, the company produces generic drugs under its own brand and through contract manufacturing for third-party laboratories.

Listed
2016
Shares outstanding
32,000,000
Major shareholders · as of 01 Aug 2025
  • PREMIUM HOLDING
    40.8%
  • Ridha Ben Ali CHARFEDDINE
    29.3%
  • Ekuity CAPITAL
    12.3%

Key figures 2025

Consolidated
View all
Revenue
149.02m TND
Net income
18.6m TND
Earnings per share
0.581 TND
P/E
16.26
Net margin
12.48%
ROE
15.96%
Dividend per share
0.625 TND

Technical indicators

View all
RSI (14)
16.9
vs 200-day average
-7.62%
vs 52-week high
-20.37%
12-month performance
+2.95%
Support
7.943
Resistance
10.223
1-month performance
-13.66%
3-month performance
-11.47%

Computed as of 24 Sept 2026. For information only, not investment advice.

UMED price · 3 months

View all
3-month change
-12.46%
3-month high
10.950
3-month low
8.670
24 Jun 202629 Sept 2026
Latest sessions
DateCloseChange %
29 Sept 20268.710-0.46%
28 Sept 20268.7500.00%
25 Sept 20268.750+0.34%
24 Sept 20268.720+0.58%
23 Sept 20268.670-1.81%

Prices adjusted for corporate actions. Source: BVMT.

Meetings and dividends

View all
Latest assembly FY 2025AGO
June 17, 2026
10HSiège de la Société UNIMED sis à la Zone Industrielle Kalâa Kébira
Latest dividend for FY 2025Dividend
September 9, 2026
0.625 DT/sharePayment Sep 9, 2026

Latest filings

View all

Latest news

View all